B2B market entry in MENA without hiring in every country
B2B market entry in MENA fails on sequencing more than on strategy. Which country first, what has to be local, and the costs that appear after you commit.
Read
Three frameworks, three different decades, three different sales motions. Most teams adopt one because a competitor uses it, then discover the mismatch nine months later in a forecast that will not hold.
A qualification framework is a checklist that decides which deals get your time. That is all it is. It does not close anything, and swapping one for another does not change a pipeline that is full of the wrong opportunities. What it does change is the speed at which you find out an opportunity is wrong, and on a small team that is most of the value available.
The three in circulation are BANT, MEDDIC and CHAMP. They are not competing products. They come from different eras and were built for different deal shapes, and most of the argument about which is best is really an argument about what someone sells.
BANT is the oldest of the three and is credited to IBM's sales organisation. Budget, Authority, Need, Timing. Four questions, asked early, producing a yes or a no on whether to keep going.
The design goal was throughput. When a rep has more inbound enquiries than hours, a four-point filter applied early is worth more than a richer model applied late. BANT is still good at exactly that, and teams that dismiss it as outdated usually have not noticed that they still run it informally under a different name.
Where it fails is the letter A. BANT assumes authority sits with a person you can identify and speak to. In most business purchases above a trivial size, it does not. Harvard Business Review described the modern purchase as involving a swelling raft of stakeholders, and a framework with one slot for authority has nowhere to record that. So the rep writes down the name of the friendliest senior person, the deal looks qualified, and it stalls six weeks later in a committee nobody logged. We wrote about who is really in that room in the B2B buying committee.
MEDDIC was created inside PTC in 1996 by Dick Dunkel, alongside Jack Napoli, for enterprise software deals that ran for quarters and involved a dozen people. Its full form, MEDDPICC, covers Metrics, Economic Buyer, Decision Criteria, Decision Process, Paper Process, Implicate the Pain, Champion and Competition.
The important difference is not the extra letters. MEDDICC, which maintains the methodology, puts it plainly: it treats qualification as a continuous process across the entire deal lifecycle, not a one-time check at the start. BANT asks once. MEDDIC asks every week, and expects the answers to move.
That is the strength and it is also the cost. MEDDPICC fields are only useful if they are filled in honestly and revisited, which is real administrative work on every open deal. Its custodians describe it as suited to complex sales with multiple stakeholders and a defined buying process, and recommend it for mid-market and enterprise teams. A two-person team selling a service at a five-figure price will fill in eight fields, find that six of them say the same thing, and quietly stop.
Two of the letters are worth stealing even if you never adopt the rest. Economic Buyer forces you to separate the person with budget authority from the person who likes you, which are different people more often than anyone wants to admit. Paper Process, the steps from decision to signature, is where deals that are genuinely won still slip a quarter. Both show up in the five places deals actually die.
CHAMP is BANT with the sequence changed. Challenges, Authority, Money, Prioritisation. Same territory, different order, and the reordering is the whole argument: start with the buyer's problem instead of your qualification needs.
This sounds cosmetic and is not, for one specific reason. A buyer who has articulated a problem in their own words has given you the material to ask about money without it landing as an interrogation. A buyer asked about budget in minute three has not, and tends to answer with a hedge that sounds like information. The same logic drives the ordering in the eight discovery questions that decide it.
The P also does something the other two frameworks miss. Prioritisation asks not whether the buyer wants this, but where it sits against everything else competing for the same budget and attention. Most lost deals are not lost to a competitor. They are lost to nothing happening, and no field in BANT records that risk.
The honest mapping, which is less interesting than a ranking would be:
High volume, short cycle, one or two people on the buyer side, deals under roughly five figures: BANT. The extra fields in MEDDIC will not be maintained and an unmaintained field is worse than no field, because it looks like data.
Long cycles, procurement involvement, four or more stakeholders, six-figure deals: MEDDPICC. The admin cost is real and it is smaller than the cost of forecasting a deal that had no economic buyer.
Founder-led selling, or any motion where the pitch is still being worked out: CHAMP. Leading with the challenge is also how you learn what you are actually selling, which is a second job the framework quietly does.
This is the part that gets left out of comparisons, and it matters more than the choice between the three.
No framework fixes a pipeline with too few opportunities in it. Qualification removes deals. A team that is short of pipeline and adopts MEDDIC will disqualify its way to an emptier forecast and a more accurate one, which is useful but is not the problem it was hoping to solve. That is a sourcing problem and it is addressed in building a pipeline you can actually forecast.
No framework survives dishonest input. The failure mode is universal and it is not laziness: a rep who believes a deal is real will fill in the fields to match that belief. The fix is not a better framework but a second person asking the questions, which is why deal reviews exist.
And no framework produces urgency. If the buyer has no date and no cost of inaction, every field can be green and the deal will still sit. Slippage, not loss, is what breaks most forecasts, and we treat it as the starting point rather than an exception in forecasting accurately.
Most small teams do not need to pick. They need four fields they will actually maintain, and the ones that earn their place are consistent across all three frameworks: what changed recently, who else has to agree, what happens if nothing is done, and what the steps are between a yes and a signature.
That is CHAMP's opening, MEDDIC's Economic Buyer and Paper Process, and BANT's Timing, without the ceremony of adopting a methodology. Add fields when a specific deal is lost for a specific reason you were not recording. Frameworks earn their complexity retrospectively or not at all. The qualification framework we use is built on that principle.
All three frameworks were designed by and for organisations with more reps than most readers of this have. BANT came out of IBM, MEDDIC out of PTC, and both assume a manager reviewing a rep's work. On a team of one or two founders, the review step that makes the framework honest does not exist, and the framework degrades into a form to be filled in.
If that is your situation, the framework is not the intervention. A standing thirty minutes each week where someone who is not on the deal reads the notes and asks why it is still open will do more than any acronym. Pick whichever of the three fits your deal shape, then spend the effort on the review rather than on the letters.
Tell us your typical deal size, how many people sit on the buyer side, and how long a normal cycle runs. We will come back with which of the three fits, the four fields worth maintaining, and what to drop.
Book a Free Consultation